COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review
<p dir="ltr">Although the possibility of asymptomatic course for COVID-19 infection in splenectomized thalassemia beta major patients is present, screening them for COVID-19 is important as the progression is still not clear.</p><h2>Other Information</h2><p dir=&...
Saved in:
| Main Author: | Lina Okar (14777164) (author) |
|---|---|
| Other Authors: | Mohammad Ali (73095) (author), Jabeed Parengal (12535533) (author), Mohamed A. Yassin (8361183) (author) |
| Published: |
2020
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis
by: Mohamed A. Yassin (16322749)
Published: (2020) -
The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: a systematic review
by: Nasrallah, Gheyath K.
Published: (2020) -
Luspatercept's use in a patient with transfusion‐dependent beta‐thalassemia and intrathoracic extramedullary hematopoiesis (EMH)
by: Mohammed Najdat Seijari (17563263)
Published: (2024) -
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation
by: Hiam Chemaitelly (439114)
Published: (2024) -
BNT162b2 Versus mRNA‐1273 Vaccines: Comparative Analysis of Long‐Term Protection Against SARS‐CoV‐2 Infection and Severe COVID‐19 in Qatar
by: Hiam Chemaitelly (439114)
Published: (2024)